In a filing, Mind Medicine Inc revealed its Chief Executive Officer Barrow Robert unloaded Company’s shares for reported $0.14 million on Mar 25 ’25. In the deal valued at $6.74 per share,21,208 shares were sold. As a result of this transaction, Barrow Robert now holds 856,556 shares worth roughly $5.3 million.
Then, Karlin Daniel sold 6,836 shares, generating $46,075 in total proceeds. Upon selling the shares at $6.74, the Chief Medical Officer now owns 446,177 shares.
Before that, Sullivan Mark sold 6,576 shares. Mind Medicine Inc shares valued at $44,322 were divested by the Chief Legal Officer at a price of $6.74 per share. As a result of the transaction, Sullivan Mark now holds 316,621 shares, worth roughly $1.96 million.
Evercore ISI initiated its Mind Medicine Inc [MNMD] rating to an Outperform in a research note published on January 28, 2025; the price target was $23. A number of analysts have revised their coverage, including Chardan Capital Markets’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. ROTH MKM started covering the stock on July 24, 2024. It rated MNMD as “a Buy”.
Price Performance Review of MNMD
On Friday, Mind Medicine Inc [NASDAQ:MNMD] saw its stock fall -3.73% to $6.19. Over the last five days, the stock has lost -7.89%. Mind Medicine Inc shares have fallen nearly -11.06% since the year began. Nevertheless, the stocks have fallen -37.22% over the past one year. While a 52-week high of $12.22 was reached on 02/14/25, a 52-week low of $5.03 was recorded on 03/04/25. SMA at 50 days reached $7.19, while 200 days put it at $7.03.
Levels Of Support And Resistance For MNMD Stock
The 24-hour chart illustrates a support level at 6.03, which if violated will result in even more drops to 5.87. On the upside, there is a resistance level at 6.42. A further resistance level may holdings at 6.65. The Relative Strength Index (RSI) on the 14-day chart is 39.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.90%. Stochastics %K at 40.37% indicates the stock is a holding.
How much short interest is there in Mind Medicine Inc?
A steep rise in short interest was recorded in Mind Medicine Inc stocks on 2025-03-14, growing by 0.49 million shares to a total of 11.37 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 10.89 million shares. There was a rise of 4.28%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 29, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $27 price target.
